PULMATRIX INCORPORATED

PULM NASDAQ

pmjalili

long

pmjalili

pulm

SilenceTradegood

Price finding solid support around 1.30. Traveling just below 50MA. Should make a move up towards 200MA and potential gap fill at 1.50+

altinAdam

Pulmatrix Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables...

altinAdam

This drug company with lung inhaler administered medicine appears to have bottomed and is moving some. Being bought by Armistice Hedge fund. I can wait. Targets will provide 3x and 10x approx.

PennyStock101

Looking for continuation and possible breakout today in PULM Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its...

Bullishcharts

Alert set for break above $1.90 for potential breakout Strong RSi and MACD

PennyStock101

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which...

mauretto432

PULM = ALLERT HARMONIC LONG PATTERNS

LionGate

Hello Everyone, The stock (PULM) experienced rapid growth (bull) within today's market. Considering the current sporadic momentum upwards, there is none-the-less an opportunity to short the stock till price consolidation. Resistance Level 1 - (4.30 - 4.50) 20 pip interval Blue Horizontal Line - (1.80 - 2.10) 30 pip interval Support Level 1 - (0.50 - 0.80) 30...

AlenCiken

Pulmatrix Drug Candidate Receives "Qualified Infectious Disease Product" (QIDP) Designation from the FDA The FDA designation adds five years of market exclusivity for Pulmatrix' inhaled product for treating fungal infections in the lungs of CF patients Under the QIDP program, which is designed to speed the development of novel drugs against important pathogens,...

AcornWealthCorp

PULM - Looking good for very speculative long.

meitshel

i see cup we might go a bit lower before up

Daddy_Trader

PULM is setting up for a good short term swing. Long term might be a little risky since SEC PRE-14A will have a June 2018 vote for a RSI proxy vote.

x2ManyPips

Momentum strategy

matt.sulli42

the 1.618 of the highlighted trend. bullish and bearish

wolfstreetswinger

been watching pulm for continuation and we have nice volume confirmation on the pivots with breakout, retesting breakout line and 50dma stock should go higher

bigdown

best time to short